|
|
||||||||
Journal of Lipid Research, Vol 37, 518-533, Copyright © 1996 by Lipid Research, Inc.
SP Tam, X Zhang and ML Koschinsky
We have studied the binding, uptake, and degradation of a recombinant form
of apolipoprotein[a] (r-apo[a]) using a cultured cell model. In HepG2 cells
and in human fibroblasts, r-apo[a] complexed with low density
lipoprotein(LDL) is bound and internalized via high affinity (Kd = 10 nM)
receptors; in both cell types, low affinity (Kd = 200-300 nM) sites also
mediate free apo[a] uptake. Using competition studies, we found that the
high affinity binding component corresponds to the LDL receptor.
Involvement of the LDL receptor in r-apo[a] uptake by fibroblasts was
confirmed using fibroblasts derived from an individual homozygous for
familial hypercholesterolemia; in contrast to normal fibroblasts, these
cells lacked the high affinity r-apo[a] binding component. Cell association
of 125I-labeled r-apo[a] was increased and decreased concomitantly with the
up- and down-regulation of the LDL receptor in response to a number of
compounds. The addition of alpha 2- macroglobulin as well as treatment with
heparinase, chondroitinase ABC, and sodium chlorate did not decrease total
specific binding of r- apo[a], suggesting that neither the low density
lipoprotein receptor- related protein nor cell surface proteoglycans are
involved in r-apo[a] clearance. The low affinity binding component present
in both fibroblasts and HepG2 cells likely corresponds to the plasminogen
receptor, as binding of r-apo[a] to these sites was specifically decreased
by the addition of plasminogen or the lysine analogue epsilon- aminocaproic
acid, but not by the addition of tissue-type plasminogen activator. Heparin
abolished uptake of r-apo[a] by the LDL receptor component only; this
indicates that apo[a] must be associated with LDL to be cleared by this
receptor. In contrast, free apo[a] can be effectively cleared by the
plasminogen receptor which may represent a significant route of clearance
for free apo[a] in vivo.
ARTICLES
Interaction of a recombinant form of apolipoprotein[a] with human fibroblasts and with the human hepatoma cell line HepG2
Department of Biochemistry, Queen's University, Kingston, Ontario, Canada.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
G. Lippi and G. Guidi Lipoprotein(a): from ancestral benefit to modern pathogen? QJM, February 1, 2000; 93(2): 75 - 84. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Allen, S. Khan, S.-p. Tam, M. Koschinsky, P. Taylor, and M. Yacoub Expression of adhesion molecules by Lp(a): a potential novel mechanism for its atherogenicity FASEB J, December 1, 1998; 12(15): 1765 - 1776. [Abstract] [Full Text] |
||||
![]() |
D. K. Bonen, A. M.L. Hausman, C. Hadjiagapiou, S. F. Skarosi, and N. O. Davidson Expression of a Recombinant Apolipoprotein(a) in HepG2 Cells. EVIDENCE FOR INTRACELLULAR ASSEMBLY OF LIPOPROTEIN(a) J. Biol. Chem., February 28, 1997; 272(9): 5659 - 5667. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |